Literature DB >> 3561699

Neurological abnormalities in Wilson's disease are reversible.

S Lingam, J Wilson, H Nazer, A P Mowat.   

Abstract

The therapeutic responses of seven children with Wilson's disease who presented with neurological disease were evaluated. Neurological abnormalities comprised intellectual deterioration in 7, conduct disorder in five, dystonia in three, choreoathetosis in three, seizures in one and hemiparesis in one. Lethargy and weight loss were present for several months in 6 children. Four children had clinically demonstrable liver disease which was fatal in two. Electroencephalography performed in two children was normal. Computed tomography (CT) of the brain in three children showed cerebral atrophy in all and areas of low attenuation in the basal ganglia which resolved on treatment in one. All patients were treated with penicillamine but, in four, triethylene tetramine (TETA) was substituted because of adverse effects. Neurological abnormalities in these patients were reversible.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3561699     DOI: 10.1055/s-2008-1052427

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  6 in total

Review 1.  Neuroimaging in Wilson disease.

Authors:  H N van Wassenaer-van Hall
Journal:  Metab Brain Dis       Date:  1997-03       Impact factor: 3.584

2.  Magnetic resonance imaging of the brain in Wilson's disease.

Authors:  H Nazer; J Brismar; M Z al-Kawi; T S Gunasekaran; K H Jorulf
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

3.  Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases.

Authors:  W Oder; G Grimm; H Kollegger; P Ferenci; B Schneider; L Deecke
Journal:  J Neurol       Date:  1991-08       Impact factor: 4.849

4.  Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease.

Authors:  G Schlaug; H Hefter; B Nebeling; V Engelbrecht; P Weiss; G Stöcklin; R J Seitz
Journal:  J Neurol       Date:  1994-10       Impact factor: 4.849

5.  Quality of Life and Psychiatric Symptoms in Wilson's Disease: the Relevance of Bipolar Disorders.

Authors:  Mg Carta; G Mura; O Sorbello; G Farina; L Demelia
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-09-18

Review 6.  Advances in Treatment of Wilson Disease.

Authors:  Annu Aggarwal; Mohit Bhatt
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.